Nasopharyngeal Carcinoma (NPC) : The value of 18-Florine Fluorodeoxyglucose (FDG) Positron Emission Tomography Computed Tomography (PET / CT) in comparison to conventional imaging modalities Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)
暂无分享,去创建一个
P. Pedrazzoli | T. Aris | S. Siena | A. Nordin | C. Rossetti | S. Secondino | C. Ferrara | N. A. Rahim | N. Rahim
[1] David J. Yang,et al. FDG-PET/CT and SPECT/CT in Oncology , 2008 .
[2] S. Kohlfuerst,et al. The Value of Imaging Methods with Emphasis on PET/CT in Head and Neck Tumours: a Comparison between a Novel Diagnostic Regime Using 18F‐FDG PET and Conventional Techniques – Own Results and Literature Review , 2007 .
[3] Jin-Ching Lin,et al. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. , 2007, International journal of radiation oncology, biology, physics.
[4] B. O'Sullivan,et al. Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer , 2006, Clinical Cancer Research.
[5] T. Yen,et al. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[6] J. Debatin,et al. Unknown primary tumors: detection with dual-modality PET/CT--initial experience. , 2005, Radiology.
[7] T. Yen,et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] P. Balaram,et al. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin. , 2004, Japanese journal of clinical oncology.
[9] J. Kwong,et al. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] Y. Shiau,et al. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy , 2002, Journal of Cancer Research and Clinical Oncology.
[11] Y. Shiau,et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium‐99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography , 2002, Cancer.
[12] C. J. Chen,et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. , 2001, The New England journal of medicine.
[13] S. Ho,et al. Comparing 18‐fluoro‐2‐deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy , 2001, Cancer.
[14] T. Yen,et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Hustinx,et al. 18FDG‐PET for the assessment of primary head and neck tumors: Clinical, computed tomography, and histopathological correlation in 38 patients , 1998, The Laryngoscope.
[16] A. Theamboonlers,et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] J. Irish,et al. The Physiologic Reservoir of Epstein‐Barr Virus Does Not Map to Upper Aerodigestive Tissues , 1998, The Laryngoscope.
[18] A. Mutirangura,et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. , 1997, British Journal of Cancer.
[19] H. Baddeley,et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. , 1997, Clinical otolaryngology and allied sciences.
[20] J. Sham,et al. Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma , 1997 .
[21] J. Freeman,et al. A majority of inverted sinonasal papillomas carries Epstein—Barr virus genomes , 1995, Cancer.
[22] J. Freeman,et al. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. , 1992, New England Journal of Medicine.
[23] S. T. Liu,et al. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification , 1990, Journal of clinical microbiology.